Drugs / TB001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05308940 | Jan → Aug 2022 | — | Shenzhen Turier Biotech Co., Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TB001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05308940 ↗ |
| Route | Subcutaneous | “subcutaneous injection of TB001 once on Day 1” NCT05308940 ↗ |